Trajan Group logo

Trajan Group(ASX) TRJ

Market CapA$42.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-86%
5 Year-91%
1 Year-64%
1 Month+81%
A$0.27
-5.36%
-0.01Today
Trajan Group last closing stock price
MetricPriceDate
Last closeAUD 0.282026-10-12
Trajan Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+14.29%AUD 0.252026-10-05
1 month+80.65%AUD 0.162026-09-11
3 month+7.69%AUD 0.262026-07-14
Year to date-60%AUD 0.702025-12-31
1 year-63.64%AUD 0.772025-10-10
3 year-78.38%AUD 1.302023-10-13
5 year-90.51%AUD 2.952021-10-13
Since inception-85.61%AUD 1.982021-06-07

Trajan Group Financials at a Glance

Market Cap

A$42.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$327.84M

Net Income (TTM)

-A$5.08M

EPS (TTM)

-A$0.00

P/E Ratio

-68.29

Dividend

A$0.00

Beta (Volatility)

-0.10 (Low)

Price

A$0.27

Volume

5,000

Open

A$0.27

Previous Close

A$0.28

Daily Range

A$0.27 - A$0.27

52-Week Range

A$0.15 - A$0.87

Estimated Earnings Date

Mar 1, 2027

TRJ News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Trajan Group

Trajan Group Holdings Limited is a global enterprise headquartered in Ringwood, Australia, specializing in the design, manufacture, marketing, and distribution of analytical and life science instruments. Established in 2011, the company operates across multiple regions, including Australia, New Zealand, the United States, and Europe, focusing on two main divisions: Analytical Products and Life Science Solutions.

Products and Services
  • Analytical Products including syringes, GC consumables, and automated systems
  • Life Science Solutions for nutrition testing and personalized health programs
  • Automation workflow solutions and micro-sampling devices
Growth Outlook
  • Revenue of AUD 77.3 million in the latest quarter indicates strong market demand
  • Operating income of AUD 2.7 million shows potential for profitability
  • Expansion into new markets enhances growth opportunities
Financial Highlights
  • Trailing twelve months (TTM) revenue of AUD 84.1 million reflects consistent performance
  • Current ratio of 2.06 suggests strong liquidity position
  • Net income margin of -0.0039 indicates room for improvement in profitability
Trajan Group Holdings Limited is positioned in the healthcare sector, focusing on medical instruments and supplies. The company has demonstrated resilience with a solid revenue base and a commitment to innovation in analytical and life science solutions. The recent quarterly performance highlights a significant revenue figure, indicating robust demand for its products. The operating income suggests that the company is on a path toward profitability, which may attract potential investors looking for growth opportunities in the healthcare industry. With a strong liquidity position, Trajan is well-equipped to navigate market challenges and capitalize on emerging opportunities.
AI Generated • Sep 22, 2026

Industry

Life Sciences Tools and Services

CEO

Stephen Andrew Tomisich

Headquarters

Ringwood, VIC 3134, AU

TRJ Financials

Key Financial Metrics (TTM)

Gross Margin

10.61%

Operating Margin

2.63%

Net Income Margin

-0.39%

Return on Equity

-0.62%

Return on Capital

2.71%

Return on Assets

-0.34%

Earnings Yield

-1.46%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$42.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

152.86M

Volume

5.00K

Avg. Volume

185.10K

Financials (TTM)

Gross Profit

A$80.59M

Operating Income

A$7.73M

EBITDA

A$21.55M

Operating Cash Flow

A$11.07M

Capital Expenditure

-A$7.50M

Free Cash Flow

A$3.57M

Cash & ST Invst.

A$12.62M

Total Debt

A$57.95M

Trajan Group Performance Analysis

Trajan Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 162,154,00050.7%
20242024-06-30AUD 155,023,000-4.4%
20252025-06-30AUD 166,462,0007.4%
20262026-06-30AUD 161,377,000-3.1%
Trajan Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-313.0%
Q42025-06-305.5%
Q22025-12-31-1.6%
Q42026-06-30-8.0%
Trajan Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD 0.0150.0%
20242024-06-30AUD -0.17N/A
20252025-06-30AUD -0.03-82.4%
20262026-06-30AUD -0.00-86.0%
Trajan Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-3185.5%
Q42025-06-3073.7%
Q22025-12-3152.5%
Q42026-06-3062.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$77.32M

-1.6%

Gross Profit

A$8.99M

-71.0%

Gross Margin

11.62%

N/A

Market Cap

A$42.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$69.04K

N/A

Employees

620

N/A

Net Income

-A$174.00K

+99.3%

EBITDA

A$7.15M

+13.0%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$12.62M

+12.3%

Total Debt

A$57.95M

+3.2%

Accounts Receivable

A$22.82M

+13.0%

Inventory

A$29.78M

+6.6%

Long Term Debt

A$49.87M

+389.5%

Short Term Debt

A$8.08M

-82.4%

Return on Assets

-0.34%

N/A

Return on Invested Capital

2.80%

N/A

Free Cash Flow

-A$1.80M

-139.8%

Operating Cash Flow

A$398.00K

-93.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ALA.AXArovella Therapeutics Limited
A$0.06+1.82%
EZZ.AXEZZ Life Science Holdings Limited
A$0.34-1.47%
AHC.AXAustco Healthcare Limited
A$0.24-2.08%
RCE.AXRecce Pharmaceuticals Ltd
A$0.29-1.69%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$6.67-0.89%
INTCIntel
$101.35-3.20%
NOKNokia
$9.90-4.44%
NVDANvidia
$226.32-1.29%

Questions About TRJ

What is the current price of Trajan Group?

Trajan Group is trading at A$0.27 per share.

What is the 52-week range for Trajan Group?

Over the past 52 weeks, Trajan Group has traded between A$0.15 and A$0.87.

How much debt does Trajan Group have?

As of the most recent reporting period, Trajan Group reported total debt of A$57.95M.

How much cash does Trajan Group have on hand?

Trajan Group reported A$12.62M in cash and cash equivalents in its most recent financial results.

What is Trajan Group’s dividend yield?

Trajan Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.